Abey Eapen
Reproductive Endocrinology Iowa City, IA Medical Doctor
NPI 1437675550 CMS profile 3388591
1360 N Dodge St, Iowa City, IA 52245
General payments
$37
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Abey Eapen of Iowa City, IA is reported in the CMS Open Payments database as having received $37 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 5th percentile of Reproductive Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $37 | 1 |
Beside peers
- Abey Eapen
- Reproductive Endocrinology median
- Middle half of Reproductive Endocrinology
- National median
In program year 2025, general payments to Abey Eapen were reported at $0. Among 986 Reproductive Endocrinology profiles paid that year, the median was $141 and the middle half received between $66 and $285.
Show as a table
| Year | Abey Eapen | Reproductive Endocrinology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $196 | $77–$425 | $163 |
| 2020 | $0 | $81 | $35–$182 | $114 |
| 2021 | $0 | $102 | $43–$247 | $132 |
| 2022 | $0 | $139 | $62–$303 | $149 |
| 2023 | $0 | $141 | $65–$285 | $160 |
| 2024 | $37 | $144 | $65–$302 | $164 |
| 2025 | $0 | $141 | $66–$285 | $169 |
Breakdown
Billing to Medicare
Part B · data year 2024 · 5 billing codesPaid by Medicare
$2,008
Medicare patients
68
Services billed
85
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 60% | |
| Arthritis | 40% | |
| Depression | 35% | |
| Diabetes | 24% | |
| Chronic kidney disease | 24% | |
| Cancer | 22% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Reproductive Endocrinology in Iowa
Jessica Kresowik
Reproductive Endocrinology · Iowa City, IA
Bradley Vanvoorhis
Reproductive Endocrinology · Iowa City, IA
Salomeh Salari
Reproductive Endocrinology · Iowa City, IA
Brian Cooper
Reproductive Endocrinology · Clive, IA
Donald Young
Reproductive Endocrinology · Clive, IA
Abigail Mancuso
Reproductive Endocrinology · Iowa City, IA
Related records
Reproductive Endocrinology in Iowa
Practitioners in the same specialty and state, ranked by reported value.
All Reproductive Endocrinology
Everyone recorded under this specialty, nationwide.
Doctors in Iowa
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.